Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 2

Status

Completed 65Recruiting 19Terminated 11Active not recruiting 6Withdrawn 4Unknown 4Not yet recruiting 4

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 74Head & Neck 20Tumor-Agnostic 4Thoracic 4Breast 3Gynecologic 2Dermatologic 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Lung Neoplasms 1Head and Neck Neoplasms 1Colorectal Neoplasms 1

Interventions

Carboplatin 133Cisplatin 130Pemetrexed 114Docetaxel 79Drug Therapy 61Gefitinib 57anlotinib 55Gemcitabine 55Erlotinib Hydrochloride 55Radiotherapy 48Bevacizumab 48pembrolizumab 47Paclitaxel 47Etoposide 44apatinib 42icotinib 41camrelizumab 39osimertinib 35Vinorelbine 31Nivolumab 31Radiosurgery 30sintilimab 29aumolertinib 25endostar protein 24durvalumab 24atezolizumab 23Endostatins 22Blood Specimen Collection 19toripalimab 18Immune Checkpoint Inhibitors 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Cetuximab × Thoracic × Clear all
NCT06101394 2024-01-25

RECOGNISE

University of Turin, Italy

Phase 2 Unknown
25 enrolled
Thoracic

Lung Neoplasms

NCT04872634 2021-07-21

SNK_ASTER

NKMAX Co., Ltd.

Phase 1/2 Unknown
24 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01166035 2010-07-20

TEXO

Medical University Innsbruck

Phase 1/2 Unknown
20 enrolled
GastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms

NCT00561054 2007-11-20

Coimbra

Grupo Portugues de Estudo do Cancro do Pulmao

Phase 2 Unknown
47 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡